Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.11 USD | +0.07% | +2.88% | -31.93% |
07/05 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
07/05 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.93% | 2.58B | |
+8.92% | 114B | |
+10.48% | 104B | |
-1.83% | 22.57B | |
-6.45% | 22.5B | |
-10.39% | 17.95B | |
-42.36% | 16.48B | |
-14.45% | 15.82B | |
+3.76% | 13.55B | |
+28.94% | 10.99B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Moonlake Immunotherapeutics Insider Sold Shares Worth $6,540,710, According to a Recent SEC Filing